Milestone Scientific(MLSS)
USD --+0.00%
Reward41Moderate
Risk50Moderate
📊75%Data
Thin -75% profit margin · Revenue down 6% YoY
MLSS
+0.0 · +0.00%
USD · NYSE MKT
Milestone Scientific | Healthcare
Earnings Deterioration
Market Cap:20.81M
ℹ️
Reward Rating
41
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
50
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MLSS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $1.00.

What is Milestone Scientific?

, a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally.

MLSS · Verdict

Moderate reward · moderate risk

MLSS's standout is balance sheet; cash flow and profitability weigh on the picture.

Based on 88% data coverage

MLSS · Verdict

What’s working & what to watch

Strengths 1

  • Balance sheet83/100

    Current ratio 2.48

Watchouts 3

  • Cash flow20/100

    -34% free-cash-flow margin

  • Profitability32/100

    -55% net margin · -136% ROE

  • Growth34/100

    Rev -5.7% CAGR · earnings -11.6%

Model-based scoring. For information only — not financial advice.

What is Milestone Scientific?

, a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company is listed on the NYSE MKT in USA, operating in the Healthcare sector, with a market capitalisation of 20.81M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (41)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap20.81M
P/E RatioN/A
Dividend YieldN/A
52 Week High1.12
52 Week Low0.2181
Last AnnualDecember
IPO Date11/3/1995
IncorporatedUSA
Shares Outstanding79M
No. of Employees17
IndustryMedical Instruments & Supplies
ExchangeNYSE MKT
Beta0.908
CurrencyUSD